Van't Oever Renske M, Zwiers Carolien, de Haas Masja, le Cessie Saskia, Lopriore Enrico, Oepkes Dick, Verweij E J T Joanne
Division of Fetal Therapy, Department of Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands.
Translational Immunohaematology, Sanquin Research and Landsteiner Laboratory Amsterdam UMC, Amsterdam, The Netherlands.
BJOG. 2024 May;131(6):769-776. doi: 10.1111/1471-0528.17674. Epub 2023 Sep 24.
Pregnant women who received at least one intrauterine transfusion (IUT) for haemolytic disease of the fetus and newborn (HDFN) in the preceding pregnancy are presumed to have a high likelihood of requiring IUTs again, often starting at an earlier gestational age. Our aim was to quantify these risks in a large national cohort.
Retrospective cohort study of a nationwide Dutch database.
The Netherlands.
All women treated in The Netherlands with IUTs for Rhesus D (RhD)- or Kell-mediated HDFN between 1999 and 2017 and their follow-up pregnancies were included. Pregnancies with an antigen-negative fetus were excluded.
Electronic patient files were searched for the number and gestational age of each IUT, and analysed using descriptive statistics and linear regression.
Percentage of women requiring one or more IUTs again in the subsequent pregnancy, and gestational age at first IUT in both pregnancies.
Of the 321 women in our study population, 21% (69) had a subsequent ongoing pregnancy at risk. IUTs were administered in 86% (59/69) of cases. In subsequent pregnancies, the median gestational age at first IUT was 3 weeks earlier (interquartile range -6.8 to 0.4) than in the preceding pregnancy.
Our study shows that pregnant women with a history of IUTs in the previous pregnancy are highly likely to require IUTs again, and on average 3 weeks earlier. Clinicians need to be aware of these risks and ensure timely referral, and close surveillance from early pregnancy onwards. Additionally, for women with a history of IUT and their caregivers, this information is essential to enable adequate preconception counselling.
在前次妊娠中因胎儿及新生儿溶血病(HDFN)接受过至少一次宫内输血(IUT)的孕妇,被认为很有可能再次需要进行宫内输血,而且往往在更早的孕周就开始。我们的目的是在一个大型全国队列中对这些风险进行量化。
对荷兰全国数据库进行回顾性队列研究。
荷兰。
纳入1999年至2017年间在荷兰因恒河猴D(RhD)或凯尔血型系统介导的HDFN接受宫内输血治疗的所有女性及其后续妊娠情况。抗原阴性胎儿的妊娠被排除。
在电子病历中查找每次宫内输血的次数和孕周,并采用描述性统计和线性回归进行分析。
后续妊娠中再次需要进行一次或多次宫内输血的女性百分比,以及两次妊娠中首次进行宫内输血时的孕周。
在我们的研究人群中的321名女性中,21%(69名)有后续处于风险中的正在进行的妊娠。86%(59/69)的病例进行了宫内输血。在后续妊娠中,首次进行宫内输血时的孕周中位数比前次妊娠早3周(四分位间距为-6.8至0.4)。
我们的研究表明,前次妊娠有宫内输血史的孕妇很有可能再次需要进行宫内输血,且平均早3周。临床医生需要意识到这些风险,并确保及时转诊,以及从妊娠早期开始密切监测。此外,对于有宫内输血史的女性及其护理人员来说,这些信息对于进行充分的孕前咨询至关重要。